Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
6.53
-0.35 (-5.09%)
At close: Mar 28, 2025, 4:00 PM
6.69
+0.16 (2.45%)
After-hours: Mar 28, 2025, 6:36 PM EDT

Atara Biotherapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
128.948.5763.5720.34-
Upgrade
Revenue Growth (YoY)
1404.02%-86.52%212.55%--
Upgrade
Cost of Revenue
168.74228.05269.99282244.65
Upgrade
Gross Profit
-39.8-219.48-206.42-261.66-244.65
Upgrade
Selling, General & Admin
38.5349.868.1378.864.4
Upgrade
Operating Expenses
38.5349.868.1378.864.4
Upgrade
Operating Income
-78.33-269.28-274.55-340.46-309.05
Upgrade
Interest Expense
-4.62-5.29-0.37--
Upgrade
Interest & Investment Income
2.115.433.062.143.28
Upgrade
Other Non Operating Income (Expenses)
0.53-0.25-0.7--
Upgrade
EBT Excluding Unusual Items
-80.31-269.38-272.56-338.33-305.78
Upgrade
Merger & Restructuring Charges
-5.11-6.73-5.96--
Upgrade
Gain (Loss) on Sale of Investments
----1.77-0.83
Upgrade
Gain (Loss) on Sale of Assets
--50.24--
Upgrade
Pretax Income
-85.42-276.11-228.29-340.1-306.61
Upgrade
Income Tax Expense
-0.010.020.010.050.02
Upgrade
Net Income
-85.4-276.13-228.3-340.14-306.62
Upgrade
Net Income to Common
-85.4-276.13-228.3-340.14-306.62
Upgrade
Shares Outstanding (Basic)
74443
Upgrade
Shares Outstanding (Diluted)
74443
Upgrade
Shares Change (YoY)
76.77%3.83%8.88%26.63%44.17%
Upgrade
EPS (Basic)
-11.41-65.19-55.96-90.78-103.63
Upgrade
EPS (Diluted)
-11.41-65.19-55.96-90.78-103.63
Upgrade
Free Cash Flow
-68.96-194.2-274.62-231.1-185.27
Upgrade
Free Cash Flow Per Share
-9.21-45.84-67.32-61.68-62.62
Upgrade
Gross Margin
-30.87%----
Upgrade
Operating Margin
-60.75%-3140.98%-431.86%-1673.85%-
Upgrade
Profit Margin
-66.23%-3220.88%-359.12%-1672.28%-
Upgrade
Free Cash Flow Margin
-53.49%-2265.25%-431.98%-1136.19%-
Upgrade
EBITDA
-73.28-264.45-268.9-331.12-300.72
Upgrade
EBITDA Margin
-56.83%----
Upgrade
D&A For EBITDA
5.054.835.659.358.33
Upgrade
EBIT
-78.33-269.28-274.55-340.46-309.05
Upgrade
EBIT Margin
-60.75%----
Upgrade
Revenue as Reported
128.948.5763.57--
Upgrade
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q